TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHAGERUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PHAGERUS

ST13

US500000097586869

Class

42

Filing

97586869

Registration

7417182

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

06/18/2024

Classification

Registered

Trademark type

Word

Nice classes

42

Filing date

09/12/2022

Registration date

06/18/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/18/2024

Last transaction

06/18/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Sungnam-si,Kyeonggi-do, KR

Examiner

GALLOWAY, JAMILLA ESPY

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

iNtRON Biotechnology, Inc.

Representatives

Susan A. Smith BALLARD SPAHR LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Publications

History of USPTO decisions and trademark events.

35 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/18/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/18/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2024

PUBO

PUBLISHED FOR OPPOSITION

04/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/29/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/14/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/14/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/14/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/08/2024

GNRT

NON-FINAL ACTION E-MAILED

02/08/2024

CNRT

NON-FINAL ACTION WRITTEN

02/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/05/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/02/2024

GNSL

LETTER OF SUSPENSION E-MAILED

02/02/2024

CNSL

SUSPENSION LETTER WRITTEN

02/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/02/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2024

ALIE

ASSIGNED TO LIE

02/02/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/22/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/22/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/22/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/22/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/13/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

07/06/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

07/06/2023

CNSI

SUSPENSION INQUIRY WRITTEN

07/06/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/05/2023

GNSL

LETTER OF SUSPENSION E-MAILED

01/05/2023

CNSL

SUSPENSION LETTER WRITTEN

01/05/2023

DOCK

ASSIGNED TO EXAMINER

12/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/27/2022

NWAP

NEW APPLICATION ENTERED

09/15/2022

Continuous trademark protection

Get notified about every new filing that threatens PHAGERUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.